Pharmaceuticals deal-making is a boon for biotech stocks. Amid the euphoria, valuations call for caution.
WSJ.com: Heard on the Street, Wall Street Journal: Markets: Heard on the Street
Fri, 02/27/2015 - 12:06pm
Pharmaceuticals deal-making is a boon for biotech stocks. Amid the euphoria, valuations call for caution.